Respiratorius AB (publ) (XSAT:RESP)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.400
+0.100 (4.35%)
At close: Jun 12, 2026

Respiratorius AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Apr '22
Other Revenue
0.030.03----
0.030.03----
Cost of Revenue
4.324.320.380.7610.66-
Gross Profit
-4.29-4.29-0.38-0.76-10.66-
Selling, General & Admin
3.153.564.65.1311.0710.19
Research & Development
0.08-----1.85
Other Operating Expenses
-4.32-4.31-0.86-1.35-11.18-0.4
Operating Expenses
2.392.667.137.072.2112.69
Operating Income
-6.68-6.95-7.51-7.83-12.87-12.69
Interest Expense
---0.05-0-0-0
Interest & Investment Income
0000.010-
Pretax Income
-6.68-6.95-7.57-7.83-12.87-12.69
Net Income
-6.68-6.95-7.57-7.83-12.87-12.69
Net Income to Common
-6.68-6.95-7.57-7.83-12.87-12.69
Shares Outstanding (Basic)
7643--
Shares Outstanding (Diluted)
7643--
Shares Change (YoY)
45.55%47.81%37.21%---
EPS (Basic)
-1.01-1.17-1.89-2.68--
EPS (Diluted)
-1.01-1.17-1.89-2.68--
Operating Margin
-22209.44%-23120.56%----
Profit Margin
-22208.69%-23119.80%----
EBITDA
-6.16-6.51-7.11-7.48-12.31-9.7
D&A For EBITDA
0.510.440.410.350.562.99
EBIT
-6.68-6.95-7.51-7.83-12.87-12.69
Revenue as Reported
4.344.340.861.35-0.4